Furthermore, exosomal KL-6, CAPN2 and SP-B levels could effectively differentiate between CTD+/ILD− and serum-KL-6-negative CTD+/ILD+, whereas serum KL-6 levels could not (Fig. S5A-B). This evidence concerns the gene CAPN2 and interstitial lung disease.